INS and metabolic dysfunction-associated steatohepatitis: Zinc, the homeostasis of which is primarily regulated in the liver, is associated with hepatic steatosis through various mechanisms, including antioxidant defense, insulin resistance, inflammation, and fibrogenesis.[45], [46], [47] While zinc supplementation may reduce fibrosis levels, it had little effect on IHTG in mouse models of MASH.48